SCHEMBL4328778

SCHEMBL4328778

CC(C)OC(Cc1ccc(NC(=O)OCc2ccc(Cl)cc2Cl)cc1)C(=O)O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.47
SMN1; SMN2 Q16637 3/20 0.46
CYP1A2 P05177 3/20 0.46
CYP2C19 P33261 3/20 0.46
KMT2A Q03164 3/20 0.46
HTT P42858 2/20 0.46
CYP3A4 P08684 2/20 0.46
GALR3 O60755 1/20 0.46
PPARA Q07869 3/20 0.42
PPARG P37231 2/20 0.42
PPARD Q03181 1/20 0.42
ALDH1A1 P00352 2/20 0.42
MEN1 O00255 2/20 0.42
CYP2D6 P10635 2/20 0.42
MAPT P10636 2/20 0.40
PTGDR2 Q9Y5Y4 1/20 0.40
NCOA1 Q15788 1/20 0.40
NCOA3 Q9Y6Q9 1/20 0.40
CYP2C9 P11712 1/20 0.39
MAPK1 P28482 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6653674 0.90 L3MBTL1 (0.51) SMN1; SMN2KMT2AHTTPPARAPPARG
SCHEMBL4341908 0.90 PPARG (0.47) SMN1; SMN2CYP1A2CYP2C19KMT2ACYP3A4
SCHEMBL4335009 0.89 ALDH1A1 (0.45) GAASMN1; SMN2CYP1A2CYP2C19KMT2A
SCHEMBL4343603 0.88 GAA (0.47) GAASMN1; SMN2CYP1A2CYP2C19KMT2A
SCHEMBL4333132 0.87 GAA (0.44) GAASMN1; SMN2CYP1A2CYP2C19KMT2A
SCHEMBL4342690 0.87 PPARG (0.48) GAASMN1; SMN2CYP1A2CYP2C19KMT2A
SCHEMBL4327189 0.87 PPARG (0.48) GAASMN1; SMN2CYP1A2CYP2C19KMT2A
SCHEMBL4329764 0.86 ACACB (0.42) SMN1; SMN2CYP1A2CYP2C19PPARAPPARG
SCHEMBL4341998 0.85 CYP1A2 (0.43) GAASMN1; SMN2CYP1A2CYP2C19KMT2A
SCHEMBL4328087 0.85 KMT2A (0.44) GAASMN1; SMN2CYP1A2CYP2C19KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7544835-B2 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-09 US disclosed
US-7544835-B2 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-09 US disclosed
US-7544835-B2 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-09 US disclosed
US-20040102634-A1 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-05-27 US disclosed
EP-1380562-A1 CARBOXYLIC ACID DERIVATIVE AND SALT THEREOF Eisai Co., Ltd. (JP) 2004-01-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040102634-A1 Carboxylic acid derivative and salt thereof GPR119, IRS1, SLC5A1 GAA 2303/4885SMN1; SMN2 3054/4885CYP1A2 1508/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.